Tech Company Financing Transactions
Agilvax Funding Round
On 5/16/2018, Agilvax landed Series A investment from Hunt Holdings and Sun Mountain Capital.
Transaction Overview
Company Name
Announced On
5/16/2018
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Hunt Holdings (Lead Investor)
Proceeds Purpose
The funds will be used to expand the pre-IND studies for its lead program AX09 in triple negative breast cancer (TNBC).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5901 Indian School Rd. Northeast
Albuquerque, NM 87110
USA
Albuquerque, NM 87110
USA
Phone
Website
Email Address
Overview
Agilvax develops targeted vaccine therapies based on its proprietory virus-like particle (VLP) platform technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Patti
Chief Financial Officer
Dee Brescia
Chief Operating Officer
Les Stewart
VP - Bus. Development
Michael Perrine
VP - R & D
Jerri Caldeira
Browse more venture capital transactions:
Prev: 5/16/2018: PriorAuthNow venture capital transaction
Next: 5/16/2018: Rael venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs